🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Kyntra Bio, Inc. (KYNB)
NASDAQ: KYNB · Real-Time Price · USD
1.560
-0.270 (-14.75%)
At close: Nov 20, 2026, 4:00 PM EST
1.565
+0.005 (0.31%)
After-hours: Nov 20, 2026, 7:30 PM EST

Kyntra Bio Stock Forecast

KYNB's stock price has decreased by -81.75% in the past year and price targets may not have had time to catch up.

Stock Price Forecast

According to 5 analysts polled by S&P Global, Kyntra Bio stock has a consensus rating of "Buy" and an average price target of $22.75. The average 1-year stock price forecast is 1,358.33% higher than the current stock price, while the lowest is $8.00 (+412.82%) and the highest is $35 (+2,143.59%).

Price Target: $22.75 (+1,358.33%)
Analyst Consensus: Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price$8.00$22.75$24$35
Change+412.82%+1358.3%+1438.5%+2143.6%

Analyst Ratings

The average analyst rating for Kyntra Bio stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Chart
RatingMay '26Jul '26Aug '26Sep '26Oct '26Nov '26
Strong Buy122333
Buy000011
Hold111111
Sell000000
Strong Sell000000
Total233455

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Lake Street
Lake Street
Buy
Maintains
$41 → $8
BuyMaintains$41 → $8+412.82%Nov 17, 2026
Oppenheimer
Oppenheimer
Buy
Maintains
$35 → $30
BuyMaintains$35 → $30+1,823.08%Nov 17, 2026
H.C. Wainwright
H.C. Wainwright
Buy
Reiterates
$43 → $18
BuyReiterates$43 → $18+1,053.85%Nov 17, 2026
Maxim Group
Maxim Group
Buy
Initiates
$35
BuyInitiates$35+2,143.59%Oct 13, 2026
William Blair
William Blair
Hold
Reiterates
n/a
HoldReiteratesn/an/aSep 1, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
5.70M
from 6.44M
Decreased by -11.49%
Revenue Next Year
7.35M
from 5.70M
Increased by 28.95%
EPS This Year
-12.41
from 45.37
EPS Next Year
-11.54
from -12.41
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026E
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
235.31M140.73M46.80M29.62M6.44M5.70M
Revenue Growth
33.46%-40.19%-66.74%-36.71%-78.26%-11.49%
Operating Income
-348.53M-301.03M-334.75M-130.96M-45.34M-52.79M
Net Income
-290.02M-293.65M-284.23M-47.58M183.45M-36.76M
EPS
----45.37-12.41
Free Cash Flow
------58.74M
No. Analysts
-----2
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High6.1M
Avg5.7M
Low5.3M

Revenue Growth

Revenue Growth202620272028
High
-5.3%
Avg
-11.5%
Low
-17.7%

EPS Forecast

EPS202620272028
High-12.41
Avg-12.41
Low-12.41

EPS Growth

EPS Growth202620272028
High-
Avg-
Low-